| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 36, 545-553, Copyright © 1989 by Canadian Anesthesiologists' Society
ARTICLES |
ED Kharasch, KT Yeo, MA Kenny and DW Amory
Department of Anesthesiology, University of Washington School of Medicine, Seattle 98195.
Atrial natriuretic factor (ANF) is a peptide released from the heart in response to atrial distension. This peptide causes diuresis, vasodilatation, decreased blood pressure, and antagonizes the renin-aldosterone and antidiuretic hormone neuraxes. The influence of cardiopulmonary bypass and cardiac surgery on the circulation and release of ANF is unknown. Plasma ANF concentrations were therefore determined in patients undergoing coronary artery revascularization (CABG) and mitral valve replacement (MVR). Peptide levels were unchanged following anaesthetic induction. Plasma ANF concentrations decreased significantly during hypothermic (less than or equal to 28 degrees C) cardiopulmonary bypass in both patient groups. After 60 minutes of cardiac bypass, ANF declined from (mean +/- SEM) 512 +/- 132 to 20 +/- 6 pg.ml-1 (P less than 0.05) during MVR, and from 178 +/- 41 to 110 +/- 48 pg.ml-1 during CABG (P less than 0.05). Rewarming during bypass was associated with an increase in ANF concentration in both groups. Heparin anticoagulation and protamine reversal had no effect on immunoreactive ANF levels. In patients undergoing CABG, there was a linear relationship between plasma ANF concentration (pg.ml-1) and right atrial pressure (mmHg) prior to cardiopulmonary bypass (r = 0.86, P less than 0.005). However, one and three hours after cardiopulmonary bypass there was no significant relationship between right atrial pressure and ANF plasma levels. These results suggest that reduction in plasma ANF concentration occurs during hypothermic cardiopulmonary bypass. Furthermore, the proportional relationship between atrial distension and circulating ANF concentration was altered following cardiac surgery.
This article has been cited by other articles:
![]() |
J. M. Costello, C. L. Backer, P. A. Checchia, C. Mavroudis, R. G. Seipelt, and D. M. Goodman Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 822 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brancaccio, G. Michielon, R. M Di Donato, D. Costa, F. Falzea, and F. Miraldi Atrial natriuretic factor in normothermic and hypothermic cardiopulmonary bypass Perfusion, May 1, 2004; 19(3): 157 - 162. [Abstract] [PDF] |
||||
![]() |
N. Hayashida, S. Chihara, H. Kashikie, E. Tayama, S. Yokose, K. Akasu, and S. Aoyagi Effects of intraoperative administration of atrial natriuretic peptide Ann. Thorac. Surg., October 1, 2000; 70(4): 1319 - 1326. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |